PROTEOSTASIS THERAPEUTICS
Proteostasis Therapeutics is discovering and developing novel small molecule therapeutics designed to control the body's protein homeostasis, or Proteostasis Network. The Proteostasis Network maintains the body's natural balance of proteins to protect us from numerous diseases. These novel therapies, or Proteostasis Regulators, are designed to treat multiple genetic and degenerative disorders associated with deficiencies of the Proteostasis Network, such as emphysema, type II diabetes, Alzheimer's Disease and Huntington's Disease.
PROTEOSTASIS THERAPEUTICS
Industry:
Biotechnology Medical Therapeutics
Founded:
2007-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.proteostasis.com
Total Employee:
51+
Status:
Active
Contact:
6172257801
Email Addresses:
[email protected]
Total Funding:
105.01 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail IPv6 ReCAPTCHA V2 Microsoft GlobalSign GlobalSign Domain Verification Akamai Hosted
Similar Organizations
AptamiR Therapeutics
AptamiR Therapeutics is a biotechnology company that focuses on developing a revolutionary treatment for human obesity.
Boston Immune Technologies & Therapeutics
This company is a Boston-based biopharmaceutical company developing immune-based approaches.
Chroma Medicine
Chroma Medicine is a new genomic medicine company working on epigenetic editing.
Intensity Therapeutics
Intensity Therapeutics is a biopharmaceutical company that provides chemotherapy treatment for cancer patients.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Ligature Therapeutics
Ligature Therapeutics is a biotech company that develops small molecules for targeted protein degradation to treat intractable diseases.
Marker Therapeutics
Marker Therapeutics is a clinical-stage developer of a transformative, non-genetically engineered, multi-antigen T cell therapy platform.
MSI Methylation Sciences
MSI Methylation Sciences is a biotechnology company that develops and markets S-Adenosyl Methionine.
Orpro Therapeutics
OrPro Therapeutics develops recombinant thioredoxin for the treatment of cystic fibrosis.
Rhovac ApS
RhoVac is an immuno-oncology company developing a novel therapeutic cancer vaccine that targets metastatic cancer cells.
Ceptur Therapeutics
Revolutionizing gene silencing by developing targeted oligonucleotide therapeutics based on U1 Adaptor technology
SiteOne Therapeutics
SiteOne Therapeutics is a San Francisco-based company that develops novel therapeutics and diagnostics.
Tetra Therapeutics
Tetra Therapeutics is a clinical stage biotechnology company developing a portfolio of therapeutic products.
Thesan Pharmaceuticals
Thesan Pharmaceuticals is a preclinical biopharmaceutical company developing novel therapeutics for skin disorders.
Transition Therapeutics
Transition Therapeutics is a biopharmaceutical company developing novel therapeutics for disease indications with large markets.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Cormorant Asset Management
Cormorant Asset Management investment in Series B - Proteostasis Therapeutics
Sanofi Ventures
Sanofi Ventures investment in Series B - Proteostasis Therapeutics
Novartis Venture Fund
Novartis Venture Fund investment in Series B - Proteostasis Therapeutics
HealthCare Ventures
HealthCare Ventures investment in Series B - Proteostasis Therapeutics
F-Prime Capital
F-Prime Capital investment in Series B - Proteostasis Therapeutics
Rock Springs Capital
Rock Springs Capital investment in Series B - Proteostasis Therapeutics
New Enterprise Associates
New Enterprise Associates investment in Series B - Proteostasis Therapeutics
Elan Corporation
Elan Corporation investment in Venture Round - Proteostasis Therapeutics
HealthCare Ventures
HealthCare Ventures investment in Series A - Proteostasis Therapeutics
Novartis Venture Fund
Novartis Venture Fund investment in Series A - Proteostasis Therapeutics
Official Site Inspections
http://www.proteostasis.com
- Host name: apache2-dap.pdx1-shared-a1-36.dreamhost.com
- IP address: 69.163.180.60
- Location: Brea United States
- Latitude: 33.9339
- Longitude: -117.8854
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 92821
